AGP Executive Report
Last update: 20 minutes agoHealth Policy & Ethics: Liechtenstein’s Prince Alois says he will veto a proposed pro-abortion law reform that would allow abortion within the first 12 weeks, reigniting debate over the country’s current exception-based rules. Medical Innovation & Access: Hansa Biopharma and SERB have closed a €115m licensing deal for Idefirix, aiming to expand desensitisation treatment access for highly sensitised kidney transplant patients across the EU/UK and also Liechtenstein, Norway, Switzerland and more. Antimicrobial Resistance: A Nordic initiative is pushing a cross-border approach to buying antibiotics plus supplier remuneration guarantees, as EU/EEA authorities warn that shared pricing and reimbursement could be a key tool against antibiotic resistance. Trade & Health-Adjacent Policy: Vietnam and EFTA (including Liechtenstein) have concluded long-running free trade agreement talks, covering areas like sanitary and phytosanitary measures and sustainable development—potentially shaping how health-related standards move with trade. Local Safety: Finnish police arrested 48 people after a football supporter clash in Lahti; investigators say one Liechtenstein citizen was among those detained.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
